Alnylam Announces Second Annual Advocacy for Impact Grants Program

Go back to Alnylam Announces Second Annual Advocacy for Impact Grants Program
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 249.59 +3.08 (1.25%)
Previous Close $246.51    52 Week High $109.10 
Open $246.51    52 Week Low $31.38 
Day High $251.81    P/E N/A 
Day Low $245.52    EPS $-1.45 
Volume 933,717